Back to Search
LORIEN NASSI, MD
MD
Pediatric Rheumatology Physician
NPI: 1811187511Individual
Specialties, Licenses & Credentials
Pediatric Rheumatology PhysicianPrimary
Pediatrics — Pediatric Rheumatology
Code: 2080P0216X
N2205(TX)
Research & Publications (8)
Primary follicular and marginal-zone lymphoma of the breast: clinical features, prognostic factors and outcome: a study by the International Extranodal Lymphoma Study Group.
PMID 19570964·Ann Oncol·2009
8-other
Positron emission tomography in the staging of patients with Hodgkin's lymphoma. A prospective multicentric study by the Intergruppo Italiano Linfomi.
PMID 17701410·Ann Hematol·2007
4-observational
Liposome-encapsulated doxorubicin in combination with cyclophosphamide, vincristine, prednisone and rituximab in patients with lymphoma and concurrent cardiac diseases or pre-treated with anthracyclines.
PMID 17654614·Hematol Oncol·2007
3-trial
Rituximab and chlorambucil as first-line treatment for low-grade ocular adnexal lymphomas.
PMID 17483948·Ann Hematol·2007
3-trial
The predictive value of positron emission tomography scanning performed after two courses of standard therapy on treatment outcome in advanced stage Hodgkin's disease.
PMID 16585014·Haematologica·2006
3-trial
Dose-dense CHOP plus rituximab (R-CHOP14) for the treatment of elderly patients with high-risk diffuse large B cell lymphoma: a pilot study.
PMID 16424645·Acta Haematol·2006
3-trial
18FDG-positron emission tomography in post treatment evaluation of residual mass in Hodgkin's lymphoma: long-term results.
PMID 16211287·Oncol Rep·2005
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 5323 Harry Hines Blvd
Dallas, TX 75390 - Phone
- (314) 645-8020
Quick Facts
- NPI
- 1811187511
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 2
- Publications
- 8
Are you this provider?
Claim Your Profile